首页> 外国专利> METHOD OF INDIRECT IMMUNIZATION OF HUMAN OVARIAN CANCER PATIENTS THROUGH SELECTION OF XENOGENEIC IMMUNOGLOBULIN FC PORTIONS

METHOD OF INDIRECT IMMUNIZATION OF HUMAN OVARIAN CANCER PATIENTS THROUGH SELECTION OF XENOGENEIC IMMUNOGLOBULIN FC PORTIONS

机译:通过选择异种免疫球蛋白FC部分的人卵巢癌患者间接免疫方法

摘要

The present document describes a method for therapeutic indirect immunization of an optimally debulked human ovarian cancer patient having a CA125 antigen level in the blood above normal levels, comprising administering to said human patient a monoclonal antibody specific to CA125 antigen having at least a xenogeneic Fc region; an immune complex formed between CA125 antigen and said monoclonal antibody having at least a xenogeneic Fc region; or a combination thereof.
机译:本文件描述了用于对血液中CA125抗原水平高于正常水平的最佳减灭的人类卵巢癌患者进行治疗性间接免疫的方法,其包括向所述人类患者施用对具有至少异种Fc区的CA125抗原特异性的单克隆抗体;在CA125抗原和所述具有至少异种Fc区的单克隆抗体之间形成的免疫复合物;或其组合。

著录项

  • 公开/公告号US2020093925A1

    专利类型

  • 公开/公告日2020-03-26

    原文格式PDF

  • 申请/专利权人 ONCOQUEST INC.;

    申请/专利号US201716482163

  • 申请日2017-07-27

  • 分类号A61K39/395;C07K16/30;C07K16/28;A61K31/282;A61K31/337;A61P35;C07K14/47;A61K39;A61K39/39;

  • 国家 US

  • 入库时间 2022-08-21 11:22:26

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号